Related Experiment Video
Updated: Sep 19, 2025

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
Published on: September 28, 2017
Melatonin Prevents Tumor Growth: The Role of Genes Controlling the Circadian Clock, the Cell Cycle, and Angiogenesis
Skarleth Cardenas-Romero1, Nadia Saderi1, Oscar Daniel Ramirez-Plascencia1
1Laboratorio de Neuroanatomía Funcional y Ritmos Biológicos, Facultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.
Abstract:
Recent evidence highlights the protective role of melatonin in a variety of pathological conditions, including multiple types of cancer. Epidemiological studies increasingly suggest that exposure to light at night suppresses melatonin synthesis in night-shift and rotating-shift workers, potentially elevating their risk of cancer development. Experimental data further indicate that melatonin can inhibit the proliferation of tumor cells, including glioblastoma-like stem cells. In the present study, we investigated the effect of melatonin on the expression of genes involved in regulating the circadian rhythm, cell cycle progression, and angiogenesis in rats exposed to constant light, a model of circadian disruption. Our findings demonstrate that melatonin administration significantly inhibited tumor growth and reduced the vascularization associated with circadian rhythm disturbance. Molecular analysis revealed that melatonin altered the circadian expression of several genes affecting tumor biology, including p53, TNF-α, Per2, VEGF-A, PDGF-C, and Ang, which are involved in circadian rhythms, cell cycle, and angiogenesis regulation. These results strengthen the existing hypothesis that circadian disruption contributes to tumor progression and suggest that melatonin exerts anticancer effects by modulating circadian gene expression and angiogenesis. Our findings provide further insight into the mechanism by which melatonin may exert oncostatic effects and highlight its potential as a therapeutic agent in cancers associated with circadian rhythm disruption.
Insights
Melatonin may fight cancer by regulating genes involved in circadian rhythms and blood vessel growth. This study shows melatonin inhibits tumor growth in a model of circadian disruption.
Area of Science:
- Chronobiology
- Oncology
- Molecular Biology
Background:
- Melatonin, a hormone regulating sleep-wake cycles, shows protective effects against various diseases, including cancer.
- Exposure to light at night disrupts melatonin synthesis, potentially increasing cancer risk, especially in shift workers.
- Melatonin has demonstrated inhibitory effects on tumor cell proliferation, including glioblastoma-like stem cells.
Purpose of the Study:
- To investigate the impact of melatonin on gene expression related to circadian rhythm, cell cycle, and angiogenesis in a rat model of circadian disruption.
- To determine if melatonin administration can counteract the effects of constant light exposure on tumor growth and vascularization.
Main Methods:
- Rats were exposed to constant light to model circadian disruption.
- Melatonin was administered to assess its effects on tumor growth, vascularization, and gene expression.
- Quantitative analysis of gene expression for key regulators of circadian rhythms (Per2), cell cycle (p53), and angiogenesis (VEGF-A, PDGF-C, Ang, TNF-α) was performed.
Main Results:
- Melatonin administration significantly inhibited tumor growth in rats exposed to constant light.
- Melatonin reduced tumor vascularization, a process often enhanced by circadian rhythm disturbance.
- Molecular analysis revealed that melatonin modulated the circadian expression of genes critical for tumor biology, including p53, TNF-α, Per2, VEGF-A, PDGF-C, and Ang.
Conclusions:
- Circadian disruption contributes to tumor progression, and melatonin can exert oncostatic effects.
- Melatonin's anticancer mechanisms involve modulating circadian gene expression and inhibiting angiogenesis.
- Melatonin shows potential as a therapeutic agent for cancers linked to circadian rhythm disruption.
Related Concept Videos
Circadian Rhythms and Gene Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Cancer
The Tumor Microenvironment

